EGFR and adenocarcinoma: When comparing patients with an OS >12 months to those with OS ≥12 months, younger age, adenocarcinoma subtype, the presence of an EGFR mutation, and contralateral lung metastasis were associated with longer OS (p-value 0.014, <0.01, 0.02, and 0.019, respectively).